CUSIP: 00888H489
Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / ALLIANZIM US EQU
-
Shares outstanding
-
750,201
-
Total 13F shares
-
742,427
-
Share change
-
+192,849
-
Total reported value
-
$20,552,702
-
Price per share
-
$27.35
-
Number of holders
-
11
-
Value change
-
+$5,516,272
-
Number of buys
-
4
-
Number of sells
-
5
Security key
00888H489
Report period
Q3 2025
Institutions
11
Top holders
10
Reporting periods
Holder history for CUSIP 00888H489
Recent filing periods:
Top shareholders of MARU - AIM ETF Products Trust - ALLIANZIM US EQU (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AIM ETF Products Trust - ALLIANZIM US EQU (MARU) as of Q3 2025
As of 30 Sep 2025,
AIM ETF Products Trust - ALLIANZIM US EQU (MARU) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
742,427 shares.
The largest 10 holders included
Arax Advisory Partners, Allianz Investment Management U.S. LLC, STEPHENS INC /AR/, ARS Wealth Advisors Group, LLC, Savant Capital, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, OLD MISSION CAPITAL LLC, COMMONWEALTH EQUITY SERVICES, LLC, BARCLAYS PLC, and AE Wealth Management LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor |
Q2 2025 Shares |
Q3 2025 Shares |
Share Diff |
Share Chg % |
Q2 2025 Value $ |
Q3 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.